ORAGENICS, INC.
SARASOTA, FLORIDA

Oragenics, Inc., founded in 1996 by Dr. Jeffrey Hillman and Dr. Robert Zahradnik, is a biotechnology company headquartered in Sarasota, Florida. The company focuses on developing novel antibiotics targeting infectious diseases resistant to conventional treatments and advancing therapies for oral mucositis, a common condition among cancer patients undergoing chemotherapy or radiation therapy. Oragenics has established exclusive collaborations with Intrexon Corporation Inc., leveraging their proprietary synthetic biology technologies to expedite the development of groundbreaking biotherapeutics for oral health issues. The company's strategic partnerships enable access to advanced transgene and cell engineering platforms, facilitating research on lantibiotics—novel antibiotic compounds known for their effectiveness in fighting resistant infections. Oragenics is advancing its lead program AG013 through clinical trials, which have demonstrated safety, efficacy, and potential regulatory designations such as Orphan Drug status within the European Union. Oragenics' leadership team includes Dr. Robert C. Koski, serving as Senior Vice President of Discovery Research with a background from notable institutions like University of Florida and Université Laval College of Medicine in Canada, as well as Mr. Daniel Sullivan who holds key financial roles and has substantial industry experience including positions at First Advantage Corporation. The company's current director roster features experts such as Dr. Jeffrey Hillman, contributing significant scientific prowess to Oragenics' pioneering projects. Additionally, the company announced a recent financing achievement with an $1.8 million registered direct offering aimed at further amplifying its research and product development capacities. Oragenics is committed to becoming a global leader in novel antibiotics while enhancing oral health through proprietary over-the-counter probiotics tailored for humans and pets.

KEY FACTS ABOUT ORAGENICS, INC.

Company name
ORAGENICS, INC.
Status
Active
Filed Number
P96000091949
FEI Number
593410522
Date of Incorporation
November 6, 1996
Age - 29 years
Home State
FL
Company Type
Domestic for Profit

CONTACTS

Website
http://oragenics.com
Phones
(813) 286-7900
(813) 286-7904
(646) 536-7009
(212) 509-4000
(727) 752-1400
(813) 229-7600

ORAGENICS, INC. NEAR ME

Principal Address
1990 Main St,
Sarasota,
FL,
34236,
US

See Also

Officers and Directors

The ORAGENICS, INC. managed by the three persons from Sarasota on following positions: Director, Chai

Alan Wdr. Dunton

Position
Director Active
From
Sarasota, FL

Charles L Pope

Position
Chai Active
From
Sarasota, FL

Robert C Koski

Position
Director Active
From
Sarasota, FL





Registered Agent is Mark Esq. Catchur

From
TAMPA, 33602

Events

May 27, 2025
AMENDMENT
March 14, 2025
AMENDMENT
December 14, 2023
AMENDMENT
December 4, 2023
AMENDMENT
July 21, 2023
AMENDMENT
January 11, 2023
AMENDMENT
February 25, 2022
AMENDMENT
July 13, 2018
AMENDMENT
June 21, 2018
AMENDMENT
January 16, 2018
AMENDMENT
December 28, 2017
AMENDMENT
December 5, 2017
AMENDMENT
November 7, 2017
AMENDED AND RESTATEDARTICLES
November 7, 2017
AMENDMENT
May 8, 2017
AMENDMENT
January 10, 2017
AMENDED AND RESTATEDARTICLES
June 2, 2014
AMENDMENT
August 28, 2011
AMENDMENT
September 22, 2010
AMENDMENT
October 28, 2009
AMENDMENT
November 20, 2006
MERGER
May 8, 2002
AMENDED AND RESTATEDARTICLES/NAME CHANGE

Annual Reports

2025
February 20, 2025
2024
February 9, 2024